79 related articles for article (PubMed ID: 17049650)
1. Low-density lipoprotein cholesterol estimation by a new formula--confirmation.
Gasko R
Int J Cardiol; 2007 Jul; 119(2):242-3; author reply 244. PubMed ID: 17049650
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein cholesterol estimation by a new formula in Indian population.
Anandaraja S; Narang R; Godeswar R; Laksmy R; Talwar KK
Int J Cardiol; 2005 Jun; 102(1):117-20. PubMed ID: 15939107
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein cholesterol estimation by the Anandaraja's formula--confirmation.
Gasko R
Lipids Health Dis; 2006 Jun; 5():18. PubMed ID: 16808846
[TBL] [Abstract][Full Text] [Related]
4. LDL cholesterol estimation using the Anandaraja's and Friedewald's formulas in schizophrenic patients treated with antipsychotic drugs.
Paz E; Hermida J; Bouzas L; Brenlla J; Tutor JC
Clin Biochem; 2008 Aug; 41(12):1002-7. PubMed ID: 18474233
[TBL] [Abstract][Full Text] [Related]
5. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
[TBL] [Abstract][Full Text] [Related]
6. Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).
Cui Y; Watson DJ; Girman CJ; Shapiro DR; Gotto AM; Hiserote P; Clearfield MB
Am J Cardiol; 2009 Sep; 104(6):829-34. PubMed ID: 19733719
[TBL] [Abstract][Full Text] [Related]
7. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
8. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.
Lu Z; Kou W; Du B; Wu Y; Zhao S; Brusco OA; Morgan JM; Capuzzi DM; ; Li S
Am J Cardiol; 2008 Jun; 101(12):1689-93. PubMed ID: 18549841
[TBL] [Abstract][Full Text] [Related]
9. HDL-cholesterol level provides additional prognosis in acute coronary syndromes.
Correia LC; Rocha MS; Esteves JP
Int J Cardiol; 2009 Aug; 136(3):307-14. PubMed ID: 18706714
[TBL] [Abstract][Full Text] [Related]
10. Martin's Formula As the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol in Indian Population.
Farheen F; Ambiger S; Jaalam K; Javali S
J Lab Physicians; 2023 Dec; 15(4):545-551. PubMed ID: 37780882
[No Abstract] [Full Text] [Related]
11. Comparative study of LDL-cholesterol levels in Thai patients by the direct method and using the Friedewald formula.
Teerakanchana T; Puavilai W; Suriyaprom K; Tungtrongchitr R
Southeast Asian J Trop Med Public Health; 2007 May; 38(3):519-27. PubMed ID: 17877229
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol.
deGoma EM; Leeper NJ; Heidenreich PA
J Am Coll Cardiol; 2008 Jan; 51(1):49-55. PubMed ID: 18174036
[TBL] [Abstract][Full Text] [Related]
13. Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction.
Al-Mallah MH; Hatahet H; Cavalcante JL; Khanal S
Cardiol J; 2009; 16(3):227-33. PubMed ID: 19437396
[TBL] [Abstract][Full Text] [Related]
14. A prudent algorithm for hyperlipoproteinemia in renal transplant recipients.
Nart A; Uslu A; Bozkaya G; Aykas A; Dogan M; Karaca B
Transplant Proc; 2009 Mar; 41(2):751-5. PubMed ID: 19328972
[TBL] [Abstract][Full Text] [Related]
15. Does LDL-C Estimation Using Anandaraja's Formula Give a Better Agreement with Direct LDL-C Estimation than the Friedewald's Formula?
Gupta S; Verma M; Singh K
Indian J Clin Biochem; 2012 Apr; 27(2):127-33. PubMed ID: 23543806
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
Razzouk L; Muntner P; Bansilal S; Kini AS; Aneja A; Mozes J; Ivan O; Jakkula M; Sharma S; Farkouh ME
Am Heart J; 2009 Aug; 158(2):277-83. PubMed ID: 19619706
[TBL] [Abstract][Full Text] [Related]
17. Non-high-density lipoprotein cholesterol in secondary prevention of coronary artery disease: a unique risk factor or redundant information?
Holcombe SM; Brubaker PH
J Cardiopulm Rehabil Prev; 2007; 27(6):386-9. PubMed ID: 18197073
[TBL] [Abstract][Full Text] [Related]
18. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
19. Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).
Guttormsen BN; Stein JH; McBride PE; Cullen MW; Gangnon R; Keevil JG
Am J Cardiol; 2007 Oct; 100(7):1130-3. PubMed ID: 17884376
[TBL] [Abstract][Full Text] [Related]
20. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
